Pregnant mom's exposure to flu vaccine kick-starts fetal immune system

Jun 01, 2007

Some researchers have hypothesized that the fetus can be exposed to and mount an immune response against allergens to which the mother has been exposed, and this may have an effect on the development of allergic sensitivity (e.g. eczema and asthma) later in an infant’s life. However this hypothesis has remained controversial because of an inability to detect antigen-specific T cells in cord blood. Recently, a newly developed technique known as MHC tetramer staining has facilitated the detection of antigen-specific T cells.

In the June 1 issue of the Journal of Clinical Investigation, a team of researchers led by Rachel Miller from Columbia University used this technique to study cord blood B and T cell immune responses following maternal vaccination against influenza with Fluzone during pregnancy.

The vaccination of pregnant women against influenza is considered safe and is recommended by the Centers for Disease Control and Prevention. The authors detected anti-Fluzone antibodies in approximately 40% of cord blood specimens examined. These results and further data reported in the study establish that B and T cell responses to antigens occur in utero following maternal vaccination against influenza, supporting the theory that the human neonatal immune system is not deficient or incompetent but, rather, capable of responding to environmental exposures.

These conclusions have important implications for determining when immune responses to environmental exposures begin.

Source: Journal of Clinical Investigation

Explore further: Allergan to cut 1,500 employees in restructuring (Update)

add to favorites email to friend print save as pdf

Related Stories

Scientists decode world's most complex human virus

Jun 12, 2014

Cytomegalovirus – or CMV - is the most complex virus known to man. Most people will in their lives become infected by CMV and, because it is a herpes virus, infection lasts a lifetime. CMV can cause severe ...

Recommended for you

Face transplants change lives, identity

4 hours ago

Patients are prepared to take significant risks in order to be considered for a face transplant, says Dr David Koppel, director of the largest craniofacial unit in the UK and Honorary Clinical Associate Professor ...

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

User comments : 0